Basel, 11 June 2018 Roche announces FDA approval for Venclexta plus Rituxan for people with previously treated chronic lymphocytic leukaemia Approval based on phase III MURANO study showing Venclexta plus Rituxan reduced risk of disease progression or death by 81% compared to bendamustine plus Rituxan Roche (SIX: RO, ROG; OTCQX: RHHBY), announced today that the... Read more
Basel, 11 June 2018 Roche announces FDA approval for Venclexta plus Rituxan for people with previously treated chronic lymphocytic leukaemia Approval based on phase III MURANO study showing Venclexta plus Rituxan reduced risk of disease progression or death by 81% compared to bendamustine plus Rituxan Roche (SIX: RO, ROG; OTCQX: RHHBY), announced today that the... Read more
Basel, 05 June 2018 FDA grants Priority Review to Roche’s Hemlibra for people with haemophilia A without factor VIII inhibitors Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) and granted Priority Review for Hemlibra® (emicizumab-kxwh) for adults and... Read more
Basel, 01 June 2018 Roche to present data for TECENTRIQ (atezolizumab) from across its genitourinary and gastrointestinal cancer immunotherapy programme at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting The data to be presented further demonstrate potential of TECENTRIQ and Avastin combination in renal cell carcinoma, a type of kidney cancer, and hepatocellular... Read more
Agilent and University of Duisburg-Essen Announce Collaboration Agreement Construction Anticipates Future Growth in Genomics Market SANTA CLARA, Calif., May 24, 2018 Agilent Technologies Inc. (NYSE: A) Agilent Technologies Inc. (NYSE: A) and the University of Duisburg-Essen has formed a collaboration agreement that brings together Agilent’s leading analytical technologies with the University’s outstanding researchers. As part... Read more
Germantown, Maryland, and Hilden, Germany, May 23, 2018 – QIAGEN today announced the worldwide launch of the new DNeasy PowerSoil Pro Kit, the next generation of sample technology for the extraction of fungal and bacterial DNA from a range of soil samples. The new DNeasy PowerSoil Pro Kits featuring a streamlined version of QIAGEN’s proprietary... Read more
EDEN PRAIRIE, Minn., May 21, 2018 /PRNewswire/ — MTS Systems Corporation (NASDAQ: MTSC), a leading global supplier of high-performance test systems and sensors, today announced receipt of a Recognition of Excellence Award for efforts to improve energy efficiency. MTS was recognized at the Xcel Energy Efficiency Expo for several energy-saving initiatives, from stopping compressed air loss... Read more
Thermo Scientific AutoXP flow computer doubles as a smart multivariable transmitter, providing a common platform for multiple applications FRANKLIN, Mass., May 15, 2018 /PRNewswire/ — Field technicians, SCADA personnel and managers across all oil and gas industry sectors can now more easily generate, manage and interpret flow data with a new flow computer that incorporates... Read more
Basel, 15 May 2018 FDA approves subcutaneous formulation of Actemra for use in active polyarticular juvenile idiopathic arthritis (pJIA), a rare form of juvenile arthritis Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved the subcutaneous (SC) formulation of Actemra® (tocilizumab) for the treatment of active... Read more
First phase of a long-term collaboration set to improve the research experience by integrating flagship solutions ChemDraw and Reaxys New York, May 8, 2018 Elsevier, the information analytics business specializing in science and health, has today announced a strategic collaboration with PerkinElmer. The first phase of this collaboration will see the integration of Elsevier’s flagship chemistry... Read more